Caffeine Citrate NDC 63323-406

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-406Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0406Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-406-03	63323040603	5 VIAL in 1 CARTON (63323-406-03) / 3 mL in 1 VIAL (63323-406-01)Marketed from Nov 19, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caffeine Citrate
Generic name (nonproprietary): caffeine citrate
Active ingredients: Caffeine citrate — 20 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078002
Marketing start: Nov 19, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)Xanthines (Chemical structure)
Identifiers: Product ID 63323-406_8d47943c-b6f3-4742-90fe-4667e19c8605SPL ID 8d47943c-b6f3-4742-90fe-4667e19c8605SPL set ID b4fb7c77-1e82-48b7-83c5-dd04ec7c5c4eRxCUI 849928UNII U26EO4675Q
Pharmacologic class: Central Nervous System Stimulant; Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463323040603 followed by a unit qualifier and the quantity

Package 63323-0406-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Caffeine citrate oral solution is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)